ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 251 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $98,000 | +180.0% | 1,652 | +223.9% | 0.00% | +200.0% |
| Q1 2021 | $35,000 | -42.6% | 510 | -36.1% | 0.00% | -66.7% |
| Q4 2020 | $61,000 | +1120.0% | 798 | +582.1% | 0.00% | +50.0% |
| Q1 2020 | $5,000 | -64.3% | 117 | -63.1% | 0.00% | -33.3% |
| Q4 2019 | $14,000 | -77.8% | 317 | -76.9% | 0.00% | -83.3% |
| Q3 2019 | $63,000 | -58.0% | 1,375 | -57.8% | 0.02% | -64.7% |
| Q3 2018 | $150,000 | – | 3,257 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
| Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
| DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
| GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
| Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
| Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
| Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
| Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
| SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
| Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |